SCHEMBL13638260

SCHEMBL13638260

C=CC[C@@](O)(CCN[C@@H](C)c1ccc(Br)cc1)c1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
MITF O75030 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR1A P08908 1/20 0.33
HTR7 P34969 1/20 0.33
HTR6 P50406 1/20 0.33
CASR P41180 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CACNA1G O43497 1/20 0.32
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
IGF1R P08069 1/20 0.31
EGFR P00533 1/20 0.31
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1904136 0.91 HTT (0.35) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL13953572 0.87 MTNR1A (0.33) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL3660804 0.84 ALDH1A1 (0.35) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL13953687 0.83 CASR (0.38) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL957448 0.83 CASR (0.38) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL15368397 0.83 GPR139 (0.35) ALDH1A1LMNAHTTSMN1; SMN2SLC6A2
SCHEMBL13624881 0.81 LPL (0.40) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL9985533 0.80 SMN1; SMN2 (0.35) ALDH1A1LMNAHTTKMT2AHTR1A
SCHEMBL14865107 0.79 CASR (0.34) ALDH1A1LMNAHTTMITFMAPT
SCHEMBL12670498 0.78 SMN1; SMN2 (0.42) ALDH1A1LMNAHTTMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009134387-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-11-05 WO disclosed